The shares of Mahalaxmi Rubtech Ltd were trading marginally lower at Rs 197 levels in the early trading hours of Thursday.
Founded 55 years ago, Mahalaxmi Rubtech (MRT) is a small-cap company with a market capitalization of Rs. 210 crores. It is engaged in the business of offset printing of blankets, manufacturing of coated fabrics, and fabric production.
The company has 13 years of experience in printing solutions with thousands of high-performance blankets. Its higher-quality fabrics have export capability, making Mahalaxmi’s Maheeka a leading brand in RFD fabrics globally. MRT serves over 10,000 customers across 40 nations globally.
As for the major developments, the insiders at Mahalaxmi Rubtech bought stock worth Rs. 7.5 crore during the last year. During the same period, they sold shares worth Rs. 3.9 crore. Insiders have purchased more stock signaling they are bullish on the future prospects of the business.
In the past five days, the stock has appreciated 29% from Rs. 151.70 per share to Rs. 197. As for the past year, it has given a multi-bagger return of 167% to its shareholders.
Rs. 1,00,000 invested a year ago would have become Rs. 2,67,000 by now resulting in multi-bagger gains of Rs. 1,67,000 for its investors.
Another plus point is the high promoter holding of 66.7% for MRT. It further strengthens the strong belief owners have in the company.
As for the quarter results for the period ending June 2022 (Q1FY23), it reported sales of Rs. 59.54 crores, a year-on-year (YoY) increase of 68.64% from Rs. 35.24 crores during the same period last year (Q2FY22). Its quarterly profit increased by 37.67% during June 2022-23 to Rs. 2.01 crore from Rs. 1.46 crore from the quarter ending June 2021-22.
Disclaimer
The content in this news article is not investment advice. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
